# Is single-shot antibiotic prophylaxis really enough for standard OMF-surgeries?

**Authors:** Lara Schorn, Daman Deep Singh, Felicitas Mrochen, Melanie Kempe, Felix Schrader, Majeed Rana, Christoph Sproll, Julian Lommen, Insa Joost

PMC · DOI: 10.1007/s00784-026-06756-4 · Clinical Oral Investigations · 2026-02-02

## TL;DR

This study shows that a single dose of antibiotics is enough for common oral and maxillofacial surgeries, reducing hospital stays and antibiotic use.

## Contribution

The study introduces and validates a shortened antibiotic prophylaxis regimen for six standard OMF surgeries.

## Key findings

- Reduced-duration antibiotic prophylaxis was not linked to adverse outcomes after risk adjustment.
- Single-shot administration was associated with shorter hospital stays.
- Shorter, tailored antibiotic regimens can be safe and effective for OMF procedures.

## Abstract

Antibiotic resistance and the development of multidrug-resistant pathogens are on the rise worldwide. This is mainly due to inappropriate or excessive use of antibiotics. There is a lack of evidence-based guidelines and studies for the administration of antibiotics in OMF surgery. In this study, a new shortened antibiotic prophylaxis regimen for six standard OMFS procedures (Fracture repair, plate removal, orthognathic surgery, TUROP, ND and bone augmentation) was introduced and evaluated for clinical outcomes and feasibility.

856 patients were enrolled in this study. They were monitored for postoperative complications such as dehiscence, fistula, signs of clinical infection, and laboratory markers of inflammation. Subgroup analyses were performed for clinically relevant procedure categories, including fractures, plate removal, and orthognathic surgery.

After risk adjustment, reduced-duration antibiotic prophylaxis was not associated with adverse postoperative outcomes. Furthermore, a more restrictive administration as a single shot was associated with a shorter length of hospital stay (from 5.83 (± 7.92) to 4.32 (± 4.88) days (p = > 0.001)).

A single dose of antibiotics was found to be sufficient for the oral and maxillofacial procedures evaluated. Implementation of a new policy of reduced antibiotic prophylaxis coincided with a shorter length of hospital stay.

This study supports the growing body of evidence suggesting that shorter, procedure-tailored antibiotic regimens can be safe and effective, potentially reducing antimicrobial resistance and adverse drug effects without compromising surgical outcomes.

## Full-text entities

- **Genes:** CRP (C-reactive protein) [NCBI Gene 1401] {aka PTX1}
- **Diseases:** nausea (MESH:D009325), diabetes mellitus (MESH:D003920), Mandibular fractures (MESH:D008337), mandible fractures (MESH:C563485), zygomatic-orbital fractures (MESH:C000721289), wound infection (MESH:D014946), facial trauma (MESH:D020220), Trauma (MESH:D014947), nosocomial infections (MESH:D003428), allergies (MESH:D004342), antibiotic (MESH:D004761), dehiscence (MESH:D013529), Fracture (MESH:D050723), abscess (MESH:D000038), Orbital fractures (MESH:D009917), bloating (MESH:C535647), diarrhea (MESH:D003967), inflammation (MESH:D007249), fistula (MESH:D005402), maxillofacial trauma (MESH:D008446), gastritis (MESH:D005756), rash (MESH:D005076), alcohol abuse (MESH:D000437), Le Fort I (MESH:C535314), infection (MESH:D007239), postoperative infection (MESH:D013530), oncological (MESH:D000072716), bacterial infections (MESH:D001424), psychiatric (MESH:D001523), infected cysts (MESH:D003560), tumors of the oral cavity and pharynx (MESH:D010610), Cancer (MESH:D009369), infectious (MESH:D003141), zygomatic arch fractures (MESH:D015051), ND (MESH:C537849), penicillin allergy (MESH:D008586), postoperative (MESH:D019106), Midfacial fractures (MESH:C537559)
- **Chemicals:** Methicillin (MESH:D008712), titanium (MESH:D014025), ceftriaxone (MESH:D002443), Amoxicillin-clavulanic acid (MESH:D019980), cefazolin (MESH:D002437), Aminopenicillins (-), clindamycin (MESH:D002981), cephalosporins (MESH:D002511)
- **Species:** Escherichia coli (E. coli, species) [taxon 562], Peptococcus sp. (species) [taxon 2049038], Staphylococcus sp. (species) [taxon 29387], Fusobacterium sp. (species) [taxon 68766], Homo sapiens (human, species) [taxon 9606], Proteus (genus) [taxon 210425], Streptococcus pyogenes (species) [taxon 1314], Haemophilus influenzae (species) [taxon 727], Bacteria Latreille et al. 1825 (Bacteria stick insect, genus) [taxon 629395], Peptostreptococcus sp. (species) [taxon 1262], Actinomyces sp. (species) [taxon 29317], Staphylococcus aureus (species) [taxon 1280], Enterococcus faecalis (species) [taxon 1351], Streptococcus pneumoniae (species) [taxon 1313]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12861997/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12861997/full.md

## References

4 references — full list in the complete paper: https://tomesphere.com/paper/PMC12861997/full.md

---
Source: https://tomesphere.com/paper/PMC12861997